- Home
- CAL vs INBX Comparison
CAL vs INBX Comparison
Compare CAL & INBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CAL
- INBX
- Stock Information
- Founded
- CAL 1878
- INBX 2010
- Country
- CAL United States
- INBX United States
- Employees
- CAL N/A
- INBX N/A
- Industry
- CAL Shoe Manufacturing
- INBX Biotechnology: Pharmaceutical Preparations
- Sector
- CAL Consumer Discretionary
- INBX Health Care
- Exchange
- CAL Nasdaq
- INBX Nasdaq
- Market Cap
- CAL 373.6M
- INBX 430.2M
- IPO Year
- CAL N/A
- INBX 2020
- Fundamental
- Price
- CAL $11.32
- INBX $80.89
- Analyst Decision
- CAL Hold
- INBX Hold
- Analyst Count
- CAL 1
- INBX 2
- Target Price
- CAL $14.00
- INBX N/A
- AVG Volume (30 Days)
- CAL 1.2M
- INBX 724.3K
- Earning Date
- CAL 12-04-2025
- INBX 11-14-2025
- Dividend Yield
- CAL 2.54%
- INBX N/A
- EPS Growth
- CAL N/A
- INBX N/A
- EPS
- CAL 1.76
- INBX N/A
- Revenue
- CAL $2,652,908,000.00
- INBX $1,400,000.00
- Revenue This Year
- CAL $1.74
- INBX $563.00
- Revenue Next Year
- CAL $5.85
- INBX $230.77
- P/E Ratio
- CAL $6.27
- INBX N/A
- Revenue Growth
- CAL N/A
- INBX N/A
- 52 Week Low
- CAL $10.33
- INBX $10.81
- 52 Week High
- CAL $33.25
- INBX $86.64
- Technical
- Relative Strength Index (RSI)
- CAL 39.81
- INBX 82.88
- Support Level
- CAL $10.33
- INBX $71.00
- Resistance Level
- CAL $11.78
- INBX $86.62
- Average True Range (ATR)
- CAL 0.66
- INBX 7.97
- MACD
- CAL -0.05
- INBX 2.27
- Stochastic Oscillator
- CAL 32.44
- INBX 90.73
About CAL Caleres Inc.
Caleres Inc is a footwear company that operates retail shoe stores and e-commerce websites, and designs, develops, sources, manufactures, and distributes footwear for people of all ages. The Company's business operations are organized into two reportable segments - famous Footwear and Brand Portfolio. The famous Footwear segment is comprised of its famous Footwear retail stores, famousfootwear.com, and famousfootwear.ca. The famous Footwear segment operated around 846 stores at the end of 2024. The Brand Portfolio segment offers retailers and consumers a cultivated portfolio of known brands. Geographically, the company generates the majority of its revenue from Domestic operations.
About INBX Inhibrx Inc.
Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.